Combined Rosiglitazone and Forskolin Have Neuroprotective Effects in SD Rats after Spinal Cord Injury

Figure 3

The mRNA and protein expression of PKA, MAP2, and NF-κB. (a) Relative PKA mRNA expression level. (b) MAP2 relative mRNA expression level. (c) Relative NF-κB mRNA expression level. (d) Relative PKA protein expression level. (e) Relative MAP2 protein expression level. (f) Relative NF-κB protein expression level. (g) Representative western blots showing the effects of rosiglitazone and G3335 on MAP2, NF-κB, and PKA. (h) cAMP expression level. Data were expressed as means±SD (n = 3). Each experiment was repeated at least three times: P < 0.05, compared with vehicle group, and # P < 0.05, compared with rosiglitazone group (one-way ANOVA followed by a Tukey–Kramer multiple comparisons posttest).